RecruitingNCT06815978

Validation of an Algorithm for the Diagnosis of Sarcopenic Obesity

Validation of ESPEN-EASO Algorithm for the Diagnosis of Sarcopenic Obesity (SO)


Sponsor

Elisa Giannetta

Enrollment

150 participants

Start Date

May 24, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The proposed research project aims to investigate sarcopenic obesity (SO), a condition characterized by the combination of high body fat and low skeletal muscle mass, with a focus on muscle function. SO has been defined according to the ESPEN-EASO algorithm, and this study aims to evaluate its validity, exploring associations with circulating biomarkers and functional outcomes. By enrolling 75 subjects with SO and a control sample of 75 subjects with non-sarcopenic obesity, the primary objective of this study is to examine the consistency of the proposed diagnostic criteria with respect to circulating biomarkers and functional outcomes. Secondary objectives include the assessment of additional variables and the detailed profiling of SO subjects through questionnaires and multidimensional tests. The ethical aspect of the present study will be guaranteed through written informed consent and protection of privacy, respecting international regulatory standards. The investigators believe that this work provides significant contributions to the understanding of sarcopenic obesity and to the validation of diagnostic criteria, with possible implications for public health. The investigators are available for further clarifications and approvals required by the Ethics Committee.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying DXA, MRI/ MRS (Magnetic Resonance Imaging /Magnetic Resonance Spectroscopy), and others for people with sarcopenic obesity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDXA

Dual energy X-ray absorptiometry

DIAGNOSTIC_TESTultrasonography

ultrasonography

DIAGNOSTIC_TESTindirect calorimetry

indirect calorimetry

DIAGNOSTIC_TESTMRI/ MRS (Magnetic Resonance Imaging /Magnetic Resonance Spectroscopy)

MRI/ MRS (Magnetic Resonance Imaging /Magnetic Resonance Spectroscopy)

DIAGNOSTIC_TESTbioimpedentiometry

bioimpedentiometry


Locations(1)

Azienda Policlinico Umberto I

Rome, RM, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06815978


Related Trials